Business · 09/04/2012
FDA Amends Animal Drug Regulations for New Sponsors of Three Antibiotic Products
The FDA is updating its regulations to reflect a change in sponsor for three antibiotic products, including lincomycin hydrochloride, penicillin G potassium, and tetracycline hydrochloride, which will now be administered by Quo Vademus, LLC, replacing Teva Animal Health, Inc.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →